Dobupro

BCWorld Pharm. Co., Ltd.🇵🇭 Food and Drug Administration - Philippines

Approval Id: 27a31fe29f1c9c4d
Drug Approval Philippines Name: Dobupro
Product Name: Dobupro
Registration Number: DRP-9050-03
Brand Name: Dobupro
Generic Name: Dobutamine (As Hydrochloride)
Dosage Form: Solution For Intravenous Infusion
Dosage Strength: 50 mg/mL
Manufacturer: BCWorld Pharm. Co., Ltd.
Importer: JLT Pharma, Inc.
Distributor: Amediqo Phils., Inc.
Issuance Date: 24 December 2021
Expiry Date: 31 October 2025
Pharmacologic Category: Cardiac Stimulant (Adrenergic and Dopaminergic Agent)
Classification: Prescription Drug (RX)

Approved

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

27a31fe29f1c9c4d

Type

Standard